Evidence map›Paper›PMID 36860538›Full record

ArticleRSC advances2023

Arumugam Marimuthu, Mahendran Logesh, Khalil El Mabrouk, Anbalagan M Ballamurugan

Abstract read
In one paragraph

Article in RSC advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Arumugam MarimuthuDepartment of Nanoscience and Technology, Bharathiar University Coimbatore-641046 India balamurugan@buc.edu.in.
Mahendran LogeshDepartment of Nanoscience and Technology, Bharathiar University Coimbatore-641046 India balamurugan@buc.edu.in.
Khalil El MabroukEuromed Engineering Faculty, Euromed Research Center, Euromed University of Fes, Eco-Campus, Campus UEMF Fes Morocco.ORCID https://orcid.org/0000-0002-7097-0737
Anbalagan M BallamuruganDepartment of Nanoscience and Technology, Bharathiar University Coimbatore-641046 India balamurugan@buc.edu.in.ORCID https://orcid.org/0000-0002-5059-587X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The doping of biologically meaningful ions into biphasic calcium phosphate (BCP) bioceramics, which exhibit biocompatibility with human body parts, has led to their effective use in biomedical applications in recent years. Doping with metal ions while changing the characteristics of the dopant ions, an arrangement of various ions in the Ca/P crystal structure. In our work, small-diameter vascular stents based on BCP and biologically appropriate ion substitute-BCP bioceramic materials were developed for cardiovascular applications. The small-diameter vascular stents were created using an extrusion process. FTIR, XRD, and FESEM were used to identify the functional groups, crystallinity, and morphology of the synthesized bioceramic materials. In addition, investigation of the blood compatibility of the 3D porous vascular stents was carried out

Identifiers

PMID36860538
PMCPMC9969537

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.